（原标题：高估值赛道产品审批收紧，考验公募产品布局能力） 市场持续上涨、热点轮动，监管正逐步收紧对高估值赛道权益基金的审批。业内人士认为，此举将降低 同质化竞争以及单一赛道过度拥挤的风险，保护投资者利益。基金公司应顺应监管逆周期调节的导向， 提升产品布局能力。 "监管层通过动态调整产品注册节奏，从供给端实施逆周期调节，抑制非理性跟风投资，是为了更好保 护投资者的利益，构建更有利于长期投资的市场环境。"王铁牛称。 在南开大学金融学教授田利辉看来，热门赛道基金审批节奏调整，其核心逻辑是"逆周期调节"与"投资 者适当性管理"的深度融合。 "当前，部分科技创新赛道估值已处于历史较高分位，资金若在情绪高点通过新发基金集中涌入，极易 催生局部泡沫，加剧市场波动。"田利辉指出，监管此举的目的是主动平抑这种"顺周期"募资冲动，防 止行业"产品供给"与"价值发现"基本功能的错位。从更深层看，这也是从源头治理"风格漂移"等顽疾， 引导行业从追逐短期热点的"题材驱动"，回归遵循契约精神的"策略驱动"。 公募应提升逆周期产品布局能力 受访人士认为，监管从产品供给端着手进行逆周期调节，有利于抑制同质化竞争，降低单一赛道过度拥 挤的风险 ...

【导读】高估值赛道审批逆周期调节，考验公募产品布局能力 中国基金报记者 张玲 市场持续上涨、热点轮动，监管正逐步收紧对高估值赛道权益基金的审批。业内人士认为， 此举将降低同质化竞争以及单一赛道过度拥挤的风险，保护投资者利益。基金公司应顺应监 管逆周期调节的导向，提升产品布局能力。 高估值赛道产品审批收紧 Wind 数据显示，过去一年，有 31 只 AI 主题基金申报但仍处于待审批状态，有 15 只提交 申请材料超 3 个月未受理，其中， 1 只产品早在去年 2 月就提交了材料；在半导体、机器 人主题产品中，约 20% 的产品上报超 3 个月未受理。 记者了解到， 2025 年以来，监管逐步收紧对估值较高的权益类新基金的审批。此前曾要求 权益基金的业绩比较基准指数最近五年滚动估值在历史 90% 分位数以下，随后又进一步调整 至 80% 分位数以下。 从近两个月的产品获批情况看，除了宽基指数基金、全市场选股的主动权益类产品外，获批 的行业主题基金多聚焦在新能源、工程机械等估值相对较低的板块。 资深基金研究员王铁牛表示，目前 AI 、芯片、机器人等热门赛道估值风险逐渐积累。例如， 中证人工智能指数市盈率达 70.8 ...

Core Viewpoint - The tightening of approvals for high-valuation equity funds is aimed at reducing homogeneous competition and the risks of overcrowding in single sectors, thereby protecting investor interests [1][2]. Group 1: Approval Tightening - In the past year, 31 AI-themed funds have been pending approval, with 15 applications submitted for over three months, indicating a slowdown in the approval process for high-valuation products [2]. - Since 2025, regulators have gradually tightened the approval of new equity funds with high valuations, adjusting the performance benchmark requirement from the 90th percentile to the 80th percentile [2]. - Recent approvals have favored industry theme funds focused on relatively low-valuation sectors such as new energy and engineering machinery [2]. Group 2: Market Dynamics - The current high valuations in popular sectors like AI and semiconductors pose risks, with the CSI Artificial Intelligence Index PE ratio at 70.86 times and the National Semiconductor Index PE ratio reaching a historical high of 151 times [2]. - The regulatory approach aims to suppress irrational investment trends and create a more favorable environment for long-term investments [2][3]. Group 3: Strategic Adjustments for Fund Companies - Fund companies are encouraged to enhance their product layout capabilities in response to regulatory adjustments, which can help mitigate risks associated with homogeneous competition [4]. - The policy direction is expected to lead to three benefits: guiding funds towards long-term value investment, optimizing resource allocation, and strengthening investor suitability management [4]. - Fund companies should prioritize sectors with reasonable valuations and align with national strategic directions, such as healthcare and consumer sectors, when applying for new products [5].

Core Insights - The article emphasizes the importance of investor education and aims to provide comprehensive wealth management support throughout the investment lifecycle through the "UP向上，投资有温度" initiative by 中信保诚基金 [1][10] Group 1: Market Trends and Investment Strategies - Investors are facing challenges in determining what and how to invest amid declining interest rates and market volatility [3][13] - The decline in interest rates is attributed to long-term trends driven by demographic changes, which significantly impact economic growth and consumption demand [5][15] - Future investment opportunities may lie in sectors encouraged by national policies, such as artificial intelligence and solid-state batteries, which can serve as stable components in investment portfolios [6][16] Group 2: Investment Methodologies - Investors are advised to focus on sectors with government support, utilize investment tools like thematic funds or broad-based indices to diversify risks, and adopt a "slow bull" logic to remain patient amid market fluctuations [6][7][16] - A comprehensive view of the entire industry chain is essential, as opportunities in AI span from upstream chip production to downstream applications [11][19] - Successful investing requires a sustainable methodology rather than relying on precise predictions of market movements, emphasizing the importance of understanding long-term trends and maintaining consistent investment practices [8][17]

Core Insights - The public fund's Q3 2025 reports highlight a recovery in the TMT sector driven by artificial intelligence and the innovative pharmaceutical industry, which is experiencing improved performance and rising sentiment [1] Group 1: AI Theme Funds - AI-themed funds have shown changes in their heavy stock structure and position ratios, indicating a strategic shift in investment focus [1] - The performance of AI-related investments is becoming increasingly significant as the sector matures and gains traction [1] Group 2: Fund Allocation Strategy - The report discusses the fund allocation strategy for Q4, suggesting a continued emphasis on sectors benefiting from AI and overseas business expansion [1] - Analysts are optimistic about the potential for further gains in the TMT and innovative pharmaceutical sectors as market conditions improve [1]

Group 1 - Over 60% of actively managed equity funds have recovered their net asset values to pre-April 7 levels as of June 9, driven by sectors such as innovative pharmaceuticals, new consumption, gold, and AI [1][2] - Funds heavily invested in innovative pharmaceuticals, such as Changcheng Pharmaceutical Industry Select A and Zhonghang Preferred Navigation A, have rebounded over 30% in the last two months, with some funds achieving returns exceeding 70% year-to-date [2][3] - AI-themed funds have also seen significant recovery, with several funds gaining over 10% from June 3 to June 9, indicating a strong performance in the AI sector [4][6] Group 2 - The market is experiencing a style shift, with recent adjustments in innovative pharmaceuticals and new consumption sectors, prompting discussions about potential short-term corrections [1][6] - The upcoming dividend distribution period for dividend assets may create selling pressure, potentially benefiting aggressive technology sectors if funds flow out of defensive assets [6][7] - There is a focus on technology stocks, particularly in AI and innovative pharmaceuticals, as they are expected to perform well due to favorable market conditions and industry catalysts [6][7]